Dianthus Therapeutics, Inc. (DNTH)

105.61USD -0.22% (-0.23)

Over 1M: -0.4%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

105 110 115
3 Aug 6 Aug 11 Aug 14 Aug 19 Aug 24 Aug 27 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Operating Income: -40.3M Q3 '25 — Operating Cash Flow: -30.6M Q4 '25 — Operating Income: -69.5M Q4 '25 — Operating Cash Flow: -47M Q1 '26 — Operating Income: -46.5M Q1 '26 — Operating Cash Flow: -28.9M Q2 '26 — Operating Income: -61.5M Q2 '26 — Operating Cash Flow: -49M -60M -45M -30M -15M 0
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Operating Income Operating Cash Flow

Figures as at 2025-12-31, reported in USD. The newest fact in the filings is dated 2026-06-30, 62 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.5
ROIC -60.3%
Accruals -3.0%
Asset turnover 0.0017×
ROA -15.8%
ROCE -18.5%
ROE -16.4%
Capex / sales —
EBITDA margin —
FCF margin —
Gross margin —
OCF / EBIT —
OCF margin —
OE margin —
Oper. margin —
Profit margin —
SBC / sales —

1 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.8
EV/Sales 2425.2×
EV/OE -26.0×
P/C 6.6×
P/B 5.0×
FCF yield -2.7%
Div. yield —
EV/EBIT —
EV/GP —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.5
RPO / sales 0.75×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

9.0
Current ratio 27.3×
ND/EBITDA 0.18
Cash runway 5.7 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 26.1×
F-score 1.3 pts
Cash / Debt —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.4
Sales/sh Y/Y -71.8%
Sales Q/Q -78.6%
Shares change +15.9%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.